Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-25 @ 1:11 PM
Study NCT ID:
NCT04235959
Status:
COMPLETED
Last Update Posted:
2023-07-06
First Post:
2020-01-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-20
First Submit QC Date:
None
Study First Post Date:
2020-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-11
Results First Submit QC Date:
None
Results First Post Date:
2023-07-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-11
Last Update Post Date:
2023-07-06
Last Update Post Date Type:
ACTUAL